Fig. 5From: EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancerOverall survival between groups: EGFR plasma at baseline (a); EGFR plasma after treatment (b); secondary T790M mutation (c£, dǂ); bone metastasis at baseline (e£, fǂ). £: all patients; ǂ: the newly diagnosed group. EGFR epidermal growth factor receptorBack to article page